Se puede utilizar como:

TERAPIA COADYUVANTE

Inmunopotenciador como coadyuvante junto a Papilocare® gel vaginal y Papilocare® gel externo

TERAPIA INDIVIDUAL

Inmunopotenciador con acción sistémica

Material informativo

Eficacia de complementos orales

Eficacia de la suplementación oral con Lactobacillus crispatus en la mejora de la microbiota vaginal y el aclaramiento del VPH.

Papilocare® forma parte de la extensa gama de productos sanitarios de Procare Health, un pionero laboratorio farmacéutico español dedicado íntegramente al desarrollo productos que cubren todas las etapas fisiológicas de la vida de la mujer.

  1. Ahmad, Md Faruque et al. “Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties.” International journal of biological macromolecules vol. 187 (2021): 769-779. doi:10.1016/j.ijbiomac.2021.06.122.
  2. Zhao, W et al. “Association between folate status and cervical intraepithelial neoplasia.” European journal of clinical nutrition vol. 70,7 (2016): 837-42. doi:10.1038/ejcn.2016.35.
  3. DI Pierro, Francesco et al. “Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial.” Minerva obstetrics and gynecology vol. 73,5 (2021): 621-631. doi:10.23736/S2724-606X.21.04752-7.
  4. Liang, Yuejuan et al. “A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia.” Infectious agents and cancer vol. 14 29. 26 Oct. 2019, doi:10.1186/s13027-019-0243-8.
  5. Brotman, Rebecca M et al. “Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.” The Journal of infectious diseases vol. 210,11 (2014): 1723-33. doi:10.1093/infdis/jiu330.
  6. Lebeau, Alizee et al. “HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources.” Nature communications vol. 13,1 1076. 28 Feb. 2022, doi:10.1038/s41467-022-28724-8.
  7. Shim, Jinhee et al. “Association Between Serum 25-Hydroxyvitamin D Level and Human Papillomavirus Cervicovaginal Infection in Women in the United States.” The Journal of infectious diseases vol. 213,12 (2016): 1886-92. doi:10.1093/infdis/jiw065.
  8. De Backer E, et al. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol. 2007 Dec 19;7:115.
  9. Brotman RM, et al. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection. J Infect Dis. 2014 Dec 1;210(11):1723-33.